ClinicalTrials.gg
Drug

Bimagrumab clinical trials

Also written BYM338 and LY3985863.

studies test it
18
open now
2
in phase 3
3
first study started
2011

How each study uses bimagrumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the bimagrumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bimagrumab
11

Development codes

BYM338
9
LY3985863
4
VER201
2

Studies by the year they started

18 studies that test it; most in 2014 (4)

Studies that test bimagrumab, by start year
YearStudies
20112
20122
20131
20144
20152
20171
20221
20241
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
16
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 1

Novartis Pharmaceuticals (12) · Eli Lilly and Company (5) · Massachusetts General Hospital (1)

Often tested with

Tested in the same studies.

Tirzepatide (3)

Studies

Open first, then newest update. How each study uses bimagrumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

What changed recently

From the registry's own updates since Oct 17, 2026.

Newly registered1

Codes

What other systems call bimagrumab · ClinicalTrials.gg INT000196

  • MeSH (NLM) C000596367bimagrumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) N15SW1DIV8BIMAGRUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q15708291bimagrumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C116852BimagrumabOne source FDA
  • DrugBank DB12584One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.